Clinical characteristics of tuberculosis-associated immune reconstitution inflammatory syndrome in North Indian population of HIV/AIDS patients receiving HAART
- PMID: 21197457
- PMCID: PMC3003953
- DOI: 10.1155/2011/239021
Clinical characteristics of tuberculosis-associated immune reconstitution inflammatory syndrome in North Indian population of HIV/AIDS patients receiving HAART
Abstract
Background & objective: IRIS is an important complication that occurs during management of HIV-TB coinfection and it poses difficulty in diagnosis. Previous studies have reported variable incidence of IRIS. The present study was undertaken to describe the pattern of TB-associated IRIS using recently proposed consensus case-definitions for TB-IRIS for its use in resource-limited settings.
Methods: A prospective analysis of ART-naïve adults started on HAART from November, 2008 to May, 2010 was done in a tertiary care hospital in north India. A total 224 patients divided into two groups, one with HIV-TB and the other with HIV alone, were followedup for a minimum period of 3 months. The diagnosis of TB was categorised as ''definitive" and ''probable".
Results: Out of a total of 224 patients, 203 completed followup. Paradoxical TB-IRIS occurred in 5 of 123 (4%) HIV-TB patients while 6 of 80 (7.5%) HIV patients developed ART-associated TB. A reduction in plasma viral load was significantly (P = .016) associated with paradoxical TB-IRIS. No identifiable risk factors were associated with the development of ART-associated TB.
Conclusion: The consensus case-definitions are useful tools in the diagnosis of TB-associated IRIS. High index of clinical suspicion is required for an early diagnosis.
Figures
Similar articles
-
A study of TB-associated immune reconstitution inflammatory syndrome using the consensus case-definition.Indian J Med Res. 2010 Jun;131:804-8. Indian J Med Res. 2010. PMID: 20571170
-
Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART.Clin Dev Immunol. 2011;2011:758350. doi: 10.1155/2011/758350. Epub 2010 Dec 8. Clin Dev Immunol. 2011. PMID: 21197091 Free PMC article.
-
Incidence and pattern of tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in patients on anti-retroviral therapy: An observational study.Indian J Tuberc. 2024 Jul;71(3):291-296. doi: 10.1016/j.ijtb.2023.05.015. Epub 2023 May 29. Indian J Tuberc. 2024. PMID: 39111937
-
Management of the immune reconstitution inflammatory syndrome.Curr HIV/AIDS Rep. 2012 Sep;9(3):238-50. doi: 10.1007/s11904-012-0129-5. Curr HIV/AIDS Rep. 2012. PMID: 22752438 Review.
-
[Tuberculosis-associated immune reconstitution inflammatory syndrome].Infez Med. 2008 Dec;16(4):193-9. Infez Med. 2008. PMID: 19155683 Review. Italian.
Cited by
-
The Epidemiology of IRIS in Southern India: An Observational Cohort Study.J Int Assoc Provid AIDS Care. 2017 Sep/Oct;16(5):475-480. doi: 10.1177/2325957417702485. Epub 2017 Apr 12. J Int Assoc Provid AIDS Care. 2017. PMID: 28399724 Free PMC article.
-
Prolonged tuberculosis-associated immune reconstitution inflammatory syndrome: characteristics and risk factors.BMC Infect Dis. 2016 Sep 27;16(1):518. doi: 10.1186/s12879-016-1850-2. BMC Infect Dis. 2016. PMID: 27677424 Free PMC article.
-
A pilot metabolomics study of tuberculosis immune reconstitution inflammatory syndrome.Int J Infect Dis. 2019 Jul;84:30-38. doi: 10.1016/j.ijid.2019.04.015. Epub 2019 Apr 19. Int J Infect Dis. 2019. PMID: 31009738 Free PMC article. Clinical Trial.
-
Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study.BMC Infect Dis. 2013 Oct 7;13:468. doi: 10.1186/1471-2334-13-468. BMC Infect Dis. 2013. PMID: 24099345 Free PMC article.
-
Tuberculosis, human immunodeficiency virus, and the immune reconstitution inflammatory syndrome.J Postgrad Med. 2017 Oct-Dec;63(4):207-209. doi: 10.4103/jpgm.JPGM_365_17. J Postgrad Med. 2017. PMID: 29022559 Free PMC article. No abstract available.
References
-
- Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archives of Internal Medicine. 2003;163(9):1009–1021. - PubMed
-
- Wood R, Maartens G, Lombard CJ. Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 2000;23(1):75–80. - PubMed
-
- Battegay M, Nüesch R, Hirschel B, Kaufmann GR. Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infectious Diseases. 2006;6(5):280–287. - PubMed
-
- Dean GL, Edwards SG, Ives NJ, et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS. 2002;16(1):75–83. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical